Researchers report genetic influences on head circumference remain stable during development and are correlated with genetic factors which contribute to intracranial volume.
Treating mouse models of astrocytomas with a new combination therapy resulted in tumor regression in 60% of the mice.
Researchers delve deeply into the genomics of 599 GBM brain cancer cases to better target the disease.